- Sosei Group Corp R&D Day TranscriptNov 10, 2023
- Q2 2023 Sosei Group Corp Earnings Presentation TranscriptAug 04, 2023
- Sosei Group Corp to Acquire Idorsia Ltd Pharmaceuticals Business in Japan and APAC TranscriptJul 20, 2023
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 23, 2023
- Full Year 2022 Sosei Group Corp Earnings Presentation TranscriptFeb 14, 2023
- Sosei Group Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Sosei Group Corp R&D Day TranscriptOct 13, 2022
- Q2 2022 Sosei Group Corp Earnings Presentation TranscriptAug 10, 2022
- Full Year 2021 Sosei Group Corp Earnings Presentation TranscriptFeb 10, 2022
- Sosei Group Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Sosei Group Corp to Discuss Newly Announced Collaboration with Neurocrine Biosciences Investor Briefing TranscriptNov 23, 2021
- Q2 2021 Sosei Group Corp Earnings Call TranscriptAug 12, 2021€11.7 (-1.68%)Earnings
- Sosei Group Corp at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Full Year 2020 Sosei Group Corp Earnings Call TranscriptFeb 15, 2021€15.4 (+7.69%)Earnings
- Sosei Group Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Sosei Group Corporation - Special Call TranscriptJan 05, 2021
- Half Year 2020 Sosei Group Corp Earnings Call TranscriptAug 13, 2020€11.1Earnings
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 25, 2020
- Sosei Group Corp at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Sosei Group Corporation - Special Call TranscriptSep 12, 2019
- Q2 2019 Sosei Group Corp Earnings Call TranscriptAug 13, 2019€22.78 (+2.61%)Earnings
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 27, 2019
Full Year 2020 Sosei Group Corp Earnings Call Transcript
Good afternoon, ladies and gentlemen. Thank you very much for joining Sosei Group Corporation's Teleconference despite a very busy schedule. In this meeting, we have Mr. Shinichi Tamura, CEO; and Mr. Chris Cargill, CFO; and myself, Nomura is joining from IR and Corporate Strategy.
First of all, Mr. Tamura and Mr. Cargill will talk about the financial results of fiscal year 2020 and the future strategy for about 50 minutes and followed by a Q&A session. The meeting is to last for about an hour. Due to the COVID-19 pandemic environment, our CFO, Chris Cargill, will be joining from overseas through a simultaneous interpretation. Please allow us to provide simultaneous interpretation. In the Q&A session, we hope that you will speak clearly and slowly.
The presentation materials were uploaded to our website on the 12th last week. Please refer to the materials. In the first presentation, we will be using the financial results materials. Prior to the beginning of the teleconference, we have some disclaimers.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)